Condition: Pancreatic Cancer · Sponsor: Fudan University
This study is a multi-center, observational study aiming at developing a machine learning-based early detection model using prospectively collected liquid biopsy samples from clinically-annotated individuals.
This description comes directly from the study's public registry record.
Xian-Jun Yu, M.D., Ph.D. · +86 21 64175590 · yuxianjun@fudanpci.org
Si Shi, M.D., Ph.D. · +86 21 64175590
Always discuss trial participation with your own doctor first.
| Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University | Shanghai, Shanghai Municipality, China | Recruiting |
| Department of Hepato-Biliary-Pancreatic-Splenic Surgery, Shanghai General Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| Department of General Sugery, Huadong Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06166147